Catalyst Wire Dossier Catalyst Wire Dossier

Roferon-A

interferon alfa-2a · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Roferon-A, covering 2008-03-04 to 2016-11-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys®) or Recombinant Interferon Alfa-2a (Roferon-A®) in Prior Clinical Studies [Phase 2, Phase 3]

See pricing